Voices
Martin Reck
esmo.org

Martin Reck: New Real-World Insights Into Immunotherapy Timing in NSCLC

Martin Reck, Head of Department at LungenClinic Grosshansdorf, shared a post on LinkedIn:

“Just published! Grateful of being involved into this fantastic work of Nikolaj Frost and colleagues together with the amazing network of nNGM Lungcancer | NNational Network Genomic Medicine

Important real world and translational information about the timing of immunotherapy in NSCLC – a prospective trial is on the way, stay tuned.”

Title: PET/CT-Guided Management of Immune Checkpoint Blockade and Post-Treatment Multi-Modal Profiling in Long-Term Responders with Metastatic Lung Cancer in the National Network Genomic Medicine Lung Cancer Germany (nNGM)

Authors: N. Frost, M. Joosten, J. Franzen, M. Wiesweg, A. Rasokat, J. Kulhavy, J. Kollmeier, N. Reinmuth, C. Grohé, J. Roeper, A. Rittmeyer, S. Heinzen, M. Wermke, C. Wesseler, P. Christopoulos, D. Kauffmann-Guerrero, A. Althoff, A. Bleckmann, M. Collienne, E. Berezucki, T. Overbeck, C. Kropf-Sanchen, F. Griesinger, M. Sebastian, M. Schuler, S. Braun, C. Wenzel, C. Furth, J. Wolf, P. Bischoff, M. Reck

Read the Full Article.

Martin Reck: New Real-World Insights Into Immunotherapy Timing in NSCLC

More posts about Immunotherapy.

 

A. Althoff A. Bleckmann A. Rasokat A. Rittmeyer C. Furth C. Grohé C. Kropf-Sanchen C. Wenzel C. Wesseler D. Kauffmann-Guerrero E. Berezucki F. Griesinger immunotherapy J. Franzen J. Kollmeier J. Kulhavy J. Roeper J. Wolf M. Collienne M. Joosten M. Reck M. Schuler M. Sebastian M. Wermke M. Wiesweg Martin Reck N. Frost N. Reinmuth P. Bischoff P. Christopoulos S. Braun S. Heinzen T. Overbeck